Enovis (ENOV) Total Non-Current Liabilities (2010 - 2026)
Enovis (ENOV) posted quarterly Total Non-Current Liabilities of $2.0 billion for Q2 2026, up 3.42% year-over-year from $1.9 billion in Q2 2025, and up 2.12% quarter-over-quarter from $1.9 billion in Q4 2025.
Enovis (ENOV) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Total Non-Current Liabilities for 17 consecutive years, with $2.0 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Non-Current Liabilities rose 3.42% year-over-year to $2.0 billion; the TTM figure through Apr 2026 stood at $2.0 billion (up 3.42% YoY), while the FY2025 annual figure was $1.9 billion, up 1.45% from the prior year.
- Total Non-Current Liabilities improved to $2.0 billion in Q2 2026 per ENOV's latest filing, from $1.9 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $3.2 billion in Q2 2022 and bottomed at $656.5 million in Q4 2022.
- Historically, Total Non-Current Liabilities has averaged $1.5 billion across 5 years, with a median of $1.9 billion in 2025.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities slumped 82.41% — and 2024, when it surged 180.61%.
- Enovis' Total Non-Current Liabilities stood at $656.5 million in 2022, then soared by 34.73% to $884.5 million in 2023, then soared by 113.8% to $1.9 billion in 2024, then rose by 1.45% to $1.9 billion in 2025, then advanced by 2.12% to $2.0 billion in 2026.
- Business Quant data shows ENOV's Total Non-Current Liabilities at $2.0 billion in Q2 2026, $1.9 billion in Q4 2025, and $2.0 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Enovis | 1.52 Bn | 1.51 Bn | 359.25 Mn | 1.92 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 1.92 Bn |
| Apr 3, 2026 | 1.96 Bn |
| Dec 31, 2025 | 1.92 Bn |
| Oct 3, 2025 | 1.97 Bn |
| Jul 4, 2025 | 1.99 Bn |
| Apr 4, 2025 | 1.89 Bn |
| Dec 31, 2024 | 1.89 Bn |
| Sep 27, 2024 | 1.90 Bn |
| Jun 28, 2024 | 1.90 Bn |
| Mar 29, 2024 | 1.92 Bn |
| Dec 31, 2023 | 884.46 Mn |
| Sep 29, 2023 | 799.46 Mn |
| Jun 30, 2023 | 801.24 Mn |
| Mar 31, 2023 | 683.79 Mn |
| Dec 31, 2022 | 656.46 Mn |
| Sep 30, 2022 | 905.95 Mn |
| Jul 1, 2022 | 868.01 Mn |
| Apr 1, 2022 | 3.24 Bn |
| Dec 31, 2021 | 3.73 Bn |
| Oct 1, 2021 | 2.71 Bn |